Compare Crescent Energy Company Class A Common Stock (CRGY) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crescent Energy Company Class A Common Stock vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Crescent Energy Company Class A Common Stock trades at $12.7 (market cap $4.30B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.9× Crescent Energy Company Class A Common Stock's market cap, and Crescent Energy Company Class A Common Stock pays a 3.69% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Crescent Energy Company Class A Common Stock for 1 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| CRGY | HALO | |
|---|---|---|
Market Cap | $4.30B | $12.58B |
Volume | 15,201,625 | 2,179,278 |
Sector | Energy | Health |
52-Week High | $15.37 | $115.22 |
52-Week Low | $7.75 | $61.63 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $9.31B | $14.49B |
Dividend Yield | 3.69% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crescent Energy Company Class A Common Stock
Crescent Energy acquires, develops, and produces oil and natural gas from onshore U.S. basins. Its portfolio includes producing assets with oil and natural gas exposure.
Read more on CRGY →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
